Krystal Clears Path To Market For Topical Gene Therapy Vyjuvek

The FDA approved Krystal Biotech's Vyjuvek for DEB • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip